title: Leprosy in a Mexican immigrant.
abstract: A new diagnosis of borderline lepromatous leprosy was established in a man who had immigrated to Kentucky from Mexico. He was placed on a World Health Organization treatment regimen consisting of dapsone, clofazimine, and rifampin. The biology of leprosy, its diagnosis, treatment, and worldwide impact are reviewed. Because of the potential for highly mobile populations to export endemic diseases, Kentucky physicians must expand their lists of differential diagnoses.
authors.affiliation: University of Kentucky Medical Center, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Baker
authors.forename: Martin
authors.initials: M
authors.lastname: Evans
authors.forename: Fernando
authors.initials: F
authors.lastname: DeCastro
authors.forename: Robert
authors.initials: R
authors.lastname: Schosser
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001707:Biopsy, Needle; D004359:Drug Therapy, Combination; D004641:Emigration and Immigration; D005500:Follow-Up Studies; D006630:Hispanic or Latino; D006801:Humans; D007629:Kentucky; D007917:Leprostatic Agents / Q000008:administration & dosage; D015439:Leprosy, Borderline / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D007917:Leprostatic Agents